We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
The UK's first authentic iced milk tea / brewed chai, combining the speciality of flavoured teas with the status of milk tea. Tuk Tuk Chai launched in 2017 with products available at 110 Sainsbury’s stores and Harvey Nichols. The firm has won multiple awards including 'Most Innovative Product' at the Lunch! 2017 trade show and were finalists for 2017 Virgin Foodpreneur. In 2018, Peter Jones of Dragon's Den made an investment offer towards the company.
days to go: Expired investment: £275,920
Skinny Tonic (ST) aims to change the traditional soft drink market by creating 100% natural, zero-sugar, zero-calorie soft drinks. The company raised £1.8 million in its first Seedrs raise in January 2020. It also raised £1.75 million in conjunction with the UK Future Fund and received the Food Matters Award for 'New drink product of the year'. ST also launched four flavours into 27 Booths stores in June 2020. It will use the investment to pioneer New Product Development (NPD), achieve British Retail Consortium (BRC) accreditation, continue to invest in staff training and recruitment, launch its fully automated canning and bottling facility, and grow the business across different verticals.

Pitch Rated

87%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £2,433,839
BrewBroker are an online marketplace, enabling anyone to buy and sell brewing services. They aim to become the world's biggest brewer, making beer production smarter and more profitable, all without owning their own brewery. They will be using the funding for continued development and launch on the platform. 
days to go: Expired investment: £380,990
Agua de Madre is craft-brewed water kefir aimed at the evergrowing no- and low- alcohol UK market. It aims to be an ethical brand that makes a delicious drink with live bacteria up to 250 billion live cultures per 100ml. The naturally low-alcohol fizzy water kefir is sold in deli's, restaurants, bars, and other food stores in London. Agua de Madre has also attracted media interest from major publications including Metro, Vogue, and Wallpaper. Furthermore, the company is planning to maximise its production potential, hire a specialist sales agency Windfall, expand to sell further in southwest London, and ramp up marketing with its PR Agency, Visible.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £250,990
@pizza is a pizza maker that aims to disrupt the £5.2 billion UK pizza and Italian restaurant market. The company asserts that its modern and fast counter operation can create hand-crafted pizzas in 90 seconds. @pizza is currently ranked the #1 restaurant in Birmingham and #1 pizza restaurant in Edinburgh for over two years with its existing fast-casual restaurants. The company plans to use ‘semi-permanent’ restaurant units situated in high traffic density suburban car parks to drive growth. @pizza believes that these restaurants can cook ten high-quality pizzas a minute, offer contactless takeaway and home delivery in the wake of COVID-19, and incorporate the UK’s first pizza drive-thru business model. The company will use the investment to broaden its customer base, giving consumers the bespoke pizza they want, as well as, how, where and when they want it without significant fixed property costs. It also aims to create franchise opportunities across UK cities.
days to go: Expired investment: £1,257,210
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph